ICD 10 CM Codes

C56.9 Malignant neoplasm of unspecified ovary
Billable Code  is a billable ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
GEMS
ICD-10-CM C56.9 converts approximately to:ICD-9-CM
2015 ICD-9-CM 183.0 Malignant neoplasm of ovary
ICD-10-CM C56.9is grouped within Diagnostic Related Group(s) (MS-DRG v30.0)
736 UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
737 UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
738 UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
739 UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
740 UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
741 UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC
754 MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC
755 MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC
756 MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC
Alternate Description
Malignant neoplasm of lower uterine segment
ICD-10-CM Index Entry
ICD-10-CM Index entries containing back-references to ICD-10-CM '.C56.9.'
Adenocarcinoma; duct; unspecified site; female
Adenocarcinoma; papillary; serous; unspecified site
Adenocarcinoma; papillocystic; unspecified site
Adenocarcinoma; pseudomucinous; unspecified site
Adenocarcinoma; serous; papillary; unspecified site
Androblastoma; malignant; unspecified site; female
Arrhenoblastoma; malignant; unspecified site; female
Cancer; ovarian
Carcinoma (malignant); endometrioid; unspecified site; female
Carcinoma (malignant); Leydig cell (testis); unspecified site; female
Carcinoma (malignant); papillary; serous; surface; unspecified site
Carcinoma (malignant); papillary; serous; unspecified site
Carcinoma (malignant); papillocystic; unspecified site
Carcinoma (malignant); pseudomucinous; unspecified site
Carcinoma (malignant); serous; papillary; unspecified site
Carcinoma (malignant); serous; surface, papillary; unspecified site
Carcinoma (malignant); Sertoli cell; unspecified site; female
Cystadenocarcinoma; endometrioid; unspecified site; female
Cystadenocarcinoma; mucinous; papillary; unspecified site
Cystadenocarcinoma; mucinous; unspecified site
Cystadenocarcinoma; papillary; mucinous; unspecified site
Cystadenocarcinoma; papillary; pseudomucinous; unspecified site
Cystadenocarcinoma; papillary; serous; unspecified site
Cystadenocarcinoma; papillary; unspecified site
Cystadenocarcinoma; pseudomucinous; papillary; unspecified site
Cystadenocarcinoma; pseudomucinous; unspecified site
Cystadenocarcinoma; serous; papillary; unspecified site
Cystadenocarcinoma; serous; unspecified site
Cystadenoma; mucinous; borderline malignancy; unspecified site
Cystadenoma; mucinous; papillary; borderline malignancy; unspecified site
Cystadenoma; papillary; borderline malignancy; unspecified site
Cystadenoma; papillary; mucinous; borderline malignancy; unspecified site
Cystadenoma; papillary; pseudomucinous; borderline malignancy; unspecified site
Cystadenoma; papillary; serous; borderline malignancy; unspecified site
Cystadenoma; pseudomucinous; borderline malignancy; unspecified site
Cystadenoma; pseudomucinous; papillary; borderline malignancy; unspecified site
Cystadenoma; serous; borderline malignancy; unspecified site
Cystadenoma; serous; papillary; borderline malignancy; unspecified site
Dysgerminoma; unspecified site; female
Leydig cell; carcinoma; unspecified site; female
Sertoli cell; carcinoma; unspecified site (male); female
Tumor; Leydig cell; malignant; unspecified site; female
Tumor; mucinous of low malignant potential; unspecified site
Tumor; papillary; mucinous of low malignant potential; unspecified site
Tumor; papillary; serous of low malignant potential; unspecified site
Tumor; polyvesicular vitelline; unspecified site; female
Tumor; serous of low malignant potential; unspecified site
Tumor; yolk sac; unspecified site; female